Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleHealth Med vs Trinity Meds

TeleHealth Med
Graded #209

Higher grade

vs+4.8999999999999915
Trinity Meds
Graded #300

Lower grade

The verdict

TeleHealth Med takes it — 66.1/100 to 61.2/100.

TeleHealth Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleHealth Med (TeleHealth Med, Inc.) is a Georgia-based telehealth weight-loss platform offering compounded semaglutide and tirzepatide in both injectable and sublingual forms through US-licensed…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleHealth Med +10
74
64
Dose & formulationTrinity Meds +1
63
64
Clinical oversightTeleHealth Med +2
76
74
Labs & monitoringEven
52
52
FulfillmentTrinity Meds +5
63
68
Contract termsTeleHealth Med +35
55
20
TeleHealth Med · left barTrinity Meds · right bar

The numbers

MetricTeleHealth MedTrinity Meds
WeighScore66.1/10061.2/100
GradeCC
Scorecard rank#209#300
Semaglutide$147/mo (starting dose, compounded)$149/mo (compounded)
TirzepatideNot disclosed$199/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
TeleHealth Med

Graded #209 · C

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

Where it loses points

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published
Trinity Meds

Graded #300 · C

Strengths

  • All-inclusive flat pricing — $149/month semaglutide, same price at every dose, no hidden fees
  • Multi-month plans cut the cost further (semaglutide to $129/month, tirzepatide to $149/month)
  • No insurance required, FSA eligible, with free shipping to your door
  • Named operating entity (Trinity Meds Inc) and US-licensed clinicians via CareValidate Health

Where it loses points

  • Doesn't publish the states it serves — you only learn eligibility after starting the assessment
  • Pharmacy partners are described as 'multiple USA certified pharmacies' but none are named
  • No terms-of-service page is posted (only a privacy policy)
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
  • Military framing is marketing; the program and pricing are open to anyone who qualifies

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard